Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gutwein P et al. – The authors data demonstrate that ADAM10 and L1–CAM have important roles during melanoma progression and both molecules represent attractive targets for therapeutical intervention of melanomas.

Related Articles

Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09    Relevance Score: 97%

Slow-growing melanoma: a dermoscopy follow-up study
British Journal of Dermatology, 10/05/09    Relevance Score: 93%

Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09    Relevance Score: 91%

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression
Modern Pathology, 11/11/09    Relevance Score: 90%

KIT as a Therapeutic Target in Melanoma
Journal of Investigative Dermatology, 10/23/09    Relevance Score: 90%

Today in Basic Science/Genetics...keeping you current

Compounding dermatologic preparations in developing countries
Dermatologic Therapy, 11/24/09

Cutaneous lesions as initial signs of interferon alpha-induced sarcoidosis: report of three new cases and review of the literature
Dermatologic Therapy, 11/23/09

BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi
British Journal of Dermatology, 11/20/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address